Clear Search sequence regions


  • amp (1)
  • cell (7)
  • cump (15)
  • cyclic (4)
  • cyclic amp (2)
  • dog (1)
  • HL 1 (5)
  • humans (1)
  • hydrolysis (5)
  • intracellular (2)
  • mice (1)
  • nucleotides cyclic (2)
  • PDE3 (1)
  • pde3 inhibitor (1)
  • PDE3A (11)
  • pde3a protein, human (1)
  • pde3a protein, rat (1)
  • PDE3B (1)
  • PDE9A (1)
  • PDEs (2)
  • phosphodiesterases (2)
  • protein human (1)
  • rat (3)
  • transcripts (1)
  • UMP (2)
  • Sizes of these terms reflect their relevance to your search.

    As previously reported, the cardiac phosphodiesterase PDE3A hydrolyzes cUMP. Moreover, cUMP-degrading activity was detected in cow and dog hearts several decades ago. Our aim was to characterize the enzyme kinetic parameters of PDE3A-mediated cUMP hydrolysis and to investigate whether cUMP and cUMP-hydrolyzing PDEs are present in cardiomyocytes. PDE3A-mediated cUMP hydrolysis was characterized in time course, inhibitor, and Michaelis-Menten kinetics experiments. Intracellular cyclic nucleotide (cNMP) concentrations and the mRNAs of cUMP-degrading PDEs were quantitated in neonatal rat cardiomyocytes (NRCMs) and murine HL-1 cardiomyogenic cells. Moreover, we investigated cUMP degradation in HL-1 cell homogenates and intact cells. Educts (cNMPs) and products (NMPs) of the PDE reactions were detected by HPLC-coupled tandem mass spectrometry. PDE3A degraded cUMP (measurement of UMP formation) with a K M value of ~143 μM and a V max value of ~42 μmol/min/mg. PDE3A hydrolyzed cAMP with a K M value of ~0.7 μM and a V max of ~1.2 μmol/min/mg (determination of AMP formation). The PDE3 inhibitor milrinone inhibited cUMP hydrolysis (determination of UMP formation) by PDE3A (K i = 57 nM). Significant amounts of cUMP as well as of PDE3A mRNA (in addition to PDE3B and PDE9A transcripts) were detected in HL-1 cells and NRCMs. Although HL-1 cell homogenates contain a milrinone-sensitive cUMP-hydrolyzing activity, intact HL-1 cells may use additional PDE3-independent mechanisms for cUMP disposal. PDE3A is a low-affinity and high-velocity PDE for cUMP. Future studies should investigate biological effects of cUMP in cardiomyocytes and the role of PDE3A in detoxifying high intracellular cUMP concentrations under pathophysiological conditions.

    Citation

    Stefan Berrisch, Jessica Ostermeyer, Volkhard Kaever, Solveig Kälble, Denise Hilfiker-Kleiner, Roland Seifert, Erich H Schneider. cUMP hydrolysis by PDE3A. Naunyn-Schmiedeberg's archives of pharmacology. 2017 Mar;390(3):269-280

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 27975297

    View Full Text